Masonic Cancer Center announces the appointment of Dr. Rahel Ghebre to newly created leadership role

Rahel Ghebre, MD, MPH, has been appointed to the leadership team of the Twin Cities’ only National Cancer Institute (NCI) designated comprehensive cancer center as the inaugural Associate Director of Diversity, Equity, and Inclusion (DEI).

Dr. Ghebre, a Professor and the Vice-Chair of DEI in the Department of Obstetrics and Gynecology, Division of Gynecologic Oncology at the University of Minnesota Medical School, and a practicing gynecologic oncologist at M Health Fairview, will lead the enhanced DEI efforts of the Masonic Cancer Center and represent inclusion initiatives for the cancer center on campus and beyond.

It is an honor to serve as an inaugural Associate Director for DEI at the Masonic Cancer Center. The goal of this role is to advance our efforts to deliver on our commitment to diversity, equity, inclusion, and justice in our work across the cancer center programs,” said Dr. Ghebre. “The work of this program will be aligned with the new emphasis from NCI to increase the diversity of our national cancer centers scientific workforce. We need to retain the diverse and talented scientists at our medical school and build an environment that invites a more diverse faculty and leaders to join our efforts in cancer science and treatment. Our community, patients, students, and faculty are looking to us to move beyond intention to action.

Ghebre’s research is focused on cervical cancer prevention and improving cancer care for women with gynecologic cancers in the US and globally by increasing access to quality care and clinical trials. Dr. Ghebre is an internationally recognized educator in gynecologic oncology and received the 2020 International Gynecologic Cancer Society (IGCS) Award for Excellence in Teaching. Dr. Ghebre co-leads the Early Pathway to Success Program for women faculty through the Center for Women in Medicine.

“Dr. Gheber’s interests in enhancing cancer outcomes for all Minnesotans - including under-represented groups - represents an important direction for the Masonic Cancer Center,” said Douglas Yee, MD, Director of the Masonic Cancer Center. “Enhancing the diversity in our workforce, people we serve, and learners is a top priority for us.”

Dr. Ghebre’s appointment is effective on January 1, 2022.

Please join us in congratulating Dr. Ghebre on her new position.

About the Masonic Cancer Center

The Masonic Cancer Center, University of Minnesota, is the Twin Cities’ only Comprehensive Cancer Center, designated ‘Outstanding’ by the National Cancer Institute. As Minnesota’s Cancer Center, we have served the entire state for more than 25 years. Our researchers, educators, and care providers have worked to discover the causes, prevention, detection, and treatment of cancer and cancer-related diseases. Learn more at